Human Gene MIR16-1 (ENST00000385271.1) from GENCODE V47lift37
  Description: microRNA 16-1 (from RefSeq NR_029486.1)
Gencode Transcript: ENST00000385271.1
Gencode Gene: ENSG00000208006.1
Transcript (Including UTRs)
   Position: hg19 chr13:50,623,109-50,623,197 Size: 89 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr13:50,623,109-50,623,197)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerHGNCOMIMPubMed
BioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in (null)
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  CS417788 - Sequence 16 from Patent WO2006048553.
FU261231 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763733 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304632 - JP 2009531018-A/199: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305130 - JP 2009531019-A/199: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119339 - JP 2013046612-A/199: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589668 - JP 2013121348-A/199: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413472 - JP 2014060993-A/199: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501683 - JP 2016025853-A/199: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526049 - Sequence 199 from Patent EP2369011.
JA526556 - Sequence 199 from Patent EP2369012.
JA527063 - Sequence 199 from Patent EP2369013.
JA535992 - Sequence 199 from Patent EP2371971.
JA787997 - Sequence 199 from Patent EP2479285.
JA788495 - Sequence 199 from Patent EP2479286.
JA810829 - Sequence 199 from Patent EP2468890.
JA811327 - Sequence 199 from Patent EP2468891.
JA811825 - Sequence 199 from Patent EP2468893.
JA812323 - Sequence 199 from Patent EP2468894.
JA812821 - Sequence 199 from Patent EP2468895.
JA813319 - Sequence 199 from Patent EP2468896.
JA813817 - Sequence 199 from Patent EP2468897.
JA814315 - Sequence 199 from Patent EP2468898.
JA814813 - Sequence 199 from Patent EP2468899.
JA817056 - Sequence 199 from Patent EP2468892.
JA825868 - Sequence 199 from Patent EP2471956.
JA826366 - Sequence 199 from Patent EP2471958.
JB024653 - Sequence 199 from Patent EP2505668.
JB025151 - Sequence 199 from Patent EP2505669.
JB079538 - Sequence 199 from Patent EP2487252.
JB080036 - Sequence 199 from Patent EP2487253.
JB080534 - Sequence 199 from Patent EP2487254.
JB081032 - Sequence 199 from Patent EP2487255.
JB081530 - Sequence 199 from Patent EP2487256.
JB082028 - Sequence 199 from Patent EP2487257.
JB082526 - Sequence 199 from Patent EP2487258.
JB083024 - Sequence 199 from Patent EP2487259.
JB083522 - Sequence 199 from Patent EP2487260.
JB084020 - Sequence 199 from Patent EP2487261.
JB084518 - Sequence 199 from Patent EP2487262.
JB085016 - Sequence 199 from Patent EP2487263.
JB087694 - Sequence 199 from Patent EP2502630.
JB147898 - Sequence 199 from Patent EP2484782.
JB148396 - Sequence 199 from Patent EP2484783.
JB153121 - Sequence 199 from Patent EP2514433.
JB153619 - Sequence 199 from Patent EP2514434.
JB622208 - Sequence 199 from Patent EP2586454.
JB622706 - Sequence 199 from Patent EP2586455.
JC001769 - Sequence 199 from Patent EP2591794.
CS266332 - Sequence 24 from Patent WO2005118806.
DD328976 - Compositions and Methods for Cancer Diagnosis and Therapy.
DI443395 - KR 1020140074997-A/16: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DL076494 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004144 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM119418 - Targeting Cells With Altered miRNA Expression.
DM168008 - COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND THERAPY OF BCL2-ASSOCIATED CANCERS.
DM174324 - COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE.
FU261066 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763568 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525804 - Nucleic acid controling mast cell degranulation.
FW361031 - MIR-15, MIR -26, MIR -31, MIR -145, MIR -147, MIR -188, MIR -215, MIR -216, MIR -331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION.
FW421486 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HI571485 - Sequence 3 from Patent EP2219653.
HI979171 - Sequence 98 from Patent EP2234483.
HV304467 - JP 2009531018-A/34: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304965 - JP 2009531019-A/34: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV342553 - JP 2011510623-A/98: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV544518 - JP 2011225570-A/2: Compositions and Methods for Cancer Diagnosis and Therapy.
HW101987 - JP 2013500034-A/114: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119174 - JP 2013046612-A/34: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367357 - JP 2012228254-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411750 - JP 2014000079-A/24: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589503 - JP 2013121348-A/34: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW596056 - JP 2013166766-A/2: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND THERAPY OF BCL2-ASSOCIATED CANCERS.
HW674096 - JP 2014217381-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW805165 - JP 2015007059-A/3: MICRO-RNAS OF THE MIR-15 FAMILY MODULATE CARDIOMYOCYTE SURVIVAL AND CARDIAC REPAIR.
HW807721 - JP 2014534810-A/16: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ043224 - JP 2015510401-A/314: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067038 - JP 2014012020-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081850 - JP 2015514392-A/314: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ406950 - JP 2015525081-A/15: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS.
HZ408195 - JP 2015528002-A/792: CHIRAL CONTROL.
HZ413307 - JP 2014060993-A/34: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427462 - JP 2014217384-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428265 - JP 2014217385-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429068 - JP 2014217386-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429871 - JP 2014217387-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ459535 - WO 2015182781-A/238: Kit or device and method for detecting pancreatic cancer.
HZ460178 - WO 2015190542-A/184: Kit or device and method for detecting biliary tract cancer.
HZ461142 - WO 2015190584-A/639: Kit or device and method for detecting prostate cancer.
HZ462362 - WO 2015190591-A/517: Kit and method for detecting breast cancer.
HZ464575 - WO 2015194615-A/393: Kit or device and method for detecting hepatic cancer.
HZ465346 - WO 2015194627-A/399: Kit and method for detecting esophageal cancer.
HZ501518 - JP 2016025853-A/34: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769128 - JP 2014223080-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058522 - Sequence 24 from Patent EP2298893.
JA059325 - Sequence 24 from Patent EP2298894.
JA073648 - Sequence 24 from Patent EP2281887.
JA104785 - Sequence 24 from Patent EP2302051.
JA106125 - Sequence 24 from Patent EP2302052.
JA106928 - Sequence 24 from Patent EP2302053.
JA107731 - Sequence 24 from Patent EP2302054.
JA108534 - Sequence 24 from Patent EP2302055.
JA109337 - Sequence 24 from Patent EP2302056.
JA191853 - Sequence 24 from Patent EP2290066.
JA192752 - Sequence 24 from Patent EP2290067.
JA193651 - Sequence 24 from Patent EP2290068.
JA194550 - Sequence 24 from Patent EP2290069.
JA195449 - Sequence 24 from Patent EP2290070.
JA196348 - Sequence 24 from Patent EP2290071.
JA197247 - Sequence 24 from Patent EP2290072.
JA198146 - Sequence 24 from Patent EP2290073.
JA199045 - Sequence 24 from Patent EP2290074.
JA199944 - Sequence 24 from Patent EP2290075.
JA200843 - Sequence 24 from Patent EP2290076.
JA217965 - Sequence 24 from Patent EP2281888.
JA226116 - Sequence 24 from Patent EP2292755.
JA228971 - Sequence 24 from Patent EP2292756.
JA257242 - Sequence 24 from Patent EP2284265.
JA278522 - Sequence 24 from Patent EP2281886.
JA284408 - Sequence 24 from Patent EP2281889.
JA292461 - Sequence 24 from Patent EP2287303.
JA317647 - Sequence 24 from Patent EP2314688.
JA374706 - Sequence 24 from Patent EP2322616.
JA525884 - Sequence 34 from Patent EP2369011.
JA526391 - Sequence 34 from Patent EP2369012.
JA526898 - Sequence 34 from Patent EP2369013.
JA535827 - Sequence 34 from Patent EP2371971.
JA787832 - Sequence 34 from Patent EP2479285.
JA788330 - Sequence 34 from Patent EP2479286.
JA810664 - Sequence 34 from Patent EP2468890.
JA811162 - Sequence 34 from Patent EP2468891.
JA811660 - Sequence 34 from Patent EP2468893.
JA812158 - Sequence 34 from Patent EP2468894.
JA812656 - Sequence 34 from Patent EP2468895.
JA813154 - Sequence 34 from Patent EP2468896.
JA813652 - Sequence 34 from Patent EP2468897.
JA814150 - Sequence 34 from Patent EP2468898.
JA814648 - Sequence 34 from Patent EP2468899.
JA816891 - Sequence 34 from Patent EP2468892.
JA825703 - Sequence 34 from Patent EP2471956.
JA826201 - Sequence 34 from Patent EP2471958.
JB024488 - Sequence 34 from Patent EP2505668.
JB024986 - Sequence 34 from Patent EP2505669.
JB037891 - Sequence 7 from Patent WO2012107841.
JB079373 - Sequence 34 from Patent EP2487252.
JB079871 - Sequence 34 from Patent EP2487253.
JB080369 - Sequence 34 from Patent EP2487254.
JB080867 - Sequence 34 from Patent EP2487255.
JB081365 - Sequence 34 from Patent EP2487256.
JB081863 - Sequence 34 from Patent EP2487257.
JB082361 - Sequence 34 from Patent EP2487258.
JB082859 - Sequence 34 from Patent EP2487259.
JB083357 - Sequence 34 from Patent EP2487260.
JB083855 - Sequence 34 from Patent EP2487261.
JB084353 - Sequence 34 from Patent EP2487262.
JB084851 - Sequence 34 from Patent EP2487263.
JB087529 - Sequence 34 from Patent EP2502630.
JB147733 - Sequence 34 from Patent EP2484782.
JB148231 - Sequence 34 from Patent EP2484783.
JB152956 - Sequence 34 from Patent EP2514433.
JB153454 - Sequence 34 from Patent EP2514434.
JB622043 - Sequence 34 from Patent EP2586454.
JB622541 - Sequence 34 from Patent EP2586455.
JC001604 - Sequence 34 from Patent EP2591794.
JC221549 - Sequence 24 from Patent EP2471923.
JC268115 - Sequence 24 from Patent EP2471924.
JC340423 - Sequence 24 from Patent EP2471922.
JC469669 - Sequence 24 from Patent EP2471921.
JC526211 - Sequence 1 from Patent WO2014083081.
JC571992 - Sequence 6 from Patent EP2759595.
JC990458 - Sequence 24 from Patent EP2808390.
JE964797 - Sequence 15 from Patent EP2863956.
JE988670 - Sequence 45 from Patent WO2015121663.
LF132441 - JP 2016506923-A/6: Composition comprising an encapsulated antagomir.
LF404321 - JP 2015509366-A/314: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714561 - JP 2016165292-A/24: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856495 - JP 2015142597-A/24: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG047719 - KR 1020150036140-A/15: Inhibitors of the MIR-15 Family of Micro-RNAs.
LG051529 - KR 1020150036642-A/795: CHIRAL CONTROL.
LG162305 - KR 1020160018451-A/6: Composition comprising an encapsulated antagomir.
LQ101302 - Sequence 7 from Patent WO2015101653.
LQ276017 - Sequence 7 from Patent WO2016071729.
LY480975 - KR 1020170010856-A/238: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495805 - KR 1020170015509-A/184: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496529 - KR 1020170018406-A/399: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498476 - KR 1020170018411-A/393: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499365 - KR 1020170018412-A/517: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY501015 - KR 1020170016490-A/639: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ215861 - JP 2017518753-A/212: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA259110 - JP 2017502699-A/7: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA353852 - JP 2018075017-A/314: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS868970 - Sequence 184 from Patent EP3156500.
MS869934 - Sequence 639 from Patent EP3156483.
MS880680 - Sequence 517 from Patent EP3156498.
MS994537 - Sequence 399 from Patent EP3159406.
CS266524 - Sequence 216 from Patent WO2005118806.
DL076686 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004336 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421678 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367549 - JP 2012228254-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411942 - JP 2014000079-A/216: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674288 - JP 2014217381-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067230 - JP 2014012020-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427654 - JP 2014217384-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428457 - JP 2014217385-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429260 - JP 2014217386-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430063 - JP 2014217387-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769320 - JP 2014223080-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058714 - Sequence 216 from Patent EP2298893.
JA059517 - Sequence 216 from Patent EP2298894.
JA073840 - Sequence 216 from Patent EP2281887.
JA104977 - Sequence 216 from Patent EP2302051.
JA106317 - Sequence 216 from Patent EP2302052.
JA107120 - Sequence 216 from Patent EP2302053.
JA107923 - Sequence 216 from Patent EP2302054.
JA108726 - Sequence 216 from Patent EP2302055.
JA109529 - Sequence 216 from Patent EP2302056.
JA192045 - Sequence 216 from Patent EP2290066.
JA192944 - Sequence 216 from Patent EP2290067.
JA193843 - Sequence 216 from Patent EP2290068.
JA194742 - Sequence 216 from Patent EP2290069.
JA195641 - Sequence 216 from Patent EP2290070.
JA196540 - Sequence 216 from Patent EP2290071.
JA197439 - Sequence 216 from Patent EP2290072.
JA198338 - Sequence 216 from Patent EP2290073.
JA199237 - Sequence 216 from Patent EP2290074.
JA200136 - Sequence 216 from Patent EP2290075.
JA201035 - Sequence 216 from Patent EP2290076.
JA218157 - Sequence 216 from Patent EP2281888.
JA226308 - Sequence 216 from Patent EP2292755.
JA229163 - Sequence 216 from Patent EP2292756.
JA257434 - Sequence 216 from Patent EP2284265.
JA278714 - Sequence 216 from Patent EP2281886.
JA284600 - Sequence 216 from Patent EP2281889.
JA292653 - Sequence 216 from Patent EP2287303.
JA317839 - Sequence 216 from Patent EP2314688.
JA374898 - Sequence 216 from Patent EP2322616.
JC221741 - Sequence 216 from Patent EP2471923.
JC268307 - Sequence 216 from Patent EP2471924.
JC340615 - Sequence 216 from Patent EP2471922.
JC469861 - Sequence 216 from Patent EP2471921.
JC990650 - Sequence 216 from Patent EP2808390.
LF714753 - JP 2016165292-A/216: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856687 - JP 2015142597-A/216: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
AF480551 - Homo sapiens miR-16-precursor-13 micro RNA, complete sequence.
FU261068 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763570 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304469 - JP 2009531018-A/36: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304967 - JP 2009531019-A/36: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119176 - JP 2013046612-A/36: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589505 - JP 2013121348-A/36: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413309 - JP 2014060993-A/36: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501520 - JP 2016025853-A/36: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA525886 - Sequence 36 from Patent EP2369011.
JA526393 - Sequence 36 from Patent EP2369012.
JA526900 - Sequence 36 from Patent EP2369013.
JA535829 - Sequence 36 from Patent EP2371971.
JA787834 - Sequence 36 from Patent EP2479285.
JA788332 - Sequence 36 from Patent EP2479286.
JA810666 - Sequence 36 from Patent EP2468890.
JA811164 - Sequence 36 from Patent EP2468891.
JA811662 - Sequence 36 from Patent EP2468893.
JA812160 - Sequence 36 from Patent EP2468894.
JA812658 - Sequence 36 from Patent EP2468895.
JA813156 - Sequence 36 from Patent EP2468896.
JA813654 - Sequence 36 from Patent EP2468897.
JA814152 - Sequence 36 from Patent EP2468898.
JA814650 - Sequence 36 from Patent EP2468899.
JA816893 - Sequence 36 from Patent EP2468892.
JA825705 - Sequence 36 from Patent EP2471956.
JA826203 - Sequence 36 from Patent EP2471958.
JB024490 - Sequence 36 from Patent EP2505668.
JB024988 - Sequence 36 from Patent EP2505669.
JB079375 - Sequence 36 from Patent EP2487252.
JB079873 - Sequence 36 from Patent EP2487253.
JB080371 - Sequence 36 from Patent EP2487254.
JB080869 - Sequence 36 from Patent EP2487255.
JB081367 - Sequence 36 from Patent EP2487256.
JB081865 - Sequence 36 from Patent EP2487257.
JB082363 - Sequence 36 from Patent EP2487258.
JB082861 - Sequence 36 from Patent EP2487259.
JB083359 - Sequence 36 from Patent EP2487260.
JB083857 - Sequence 36 from Patent EP2487261.
JB084355 - Sequence 36 from Patent EP2487262.
JB084853 - Sequence 36 from Patent EP2487263.
JB087531 - Sequence 36 from Patent EP2502630.
JB147735 - Sequence 36 from Patent EP2484782.
JB148233 - Sequence 36 from Patent EP2484783.
JB152958 - Sequence 36 from Patent EP2514433.
JB153456 - Sequence 36 from Patent EP2514434.
JB622045 - Sequence 36 from Patent EP2586454.
JB622543 - Sequence 36 from Patent EP2586455.
JC001606 - Sequence 36 from Patent EP2591794.
FW364051 - Oligonucleotides for modulating target RNA activity.
HI560816 - Sequence 31 from Patent EP2190992.
HI571494 - Sequence 12 from Patent EP2219653.
HI965392 - Sequence 677 from Patent WO2010139812.
HI965866 - Sequence 186 from Patent WO2010139811.
HI966732 - Sequence 186 from Patent WO2010139810.
HV593917 - JP 2010538653-A/31: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594941 - JP 2010539959-A/322: Micromirs.
HW101935 - JP 2013500034-A/62: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW805174 - JP 2015007059-A/12: MICRO-RNAS OF THE MIR-15 FAMILY MODULATE CARDIOMYOCYTE SURVIVAL AND CARDIAC REPAIR.
HW913297 - JP 2015504307-A/57: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ073927 - JP 2013535982-A/18: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083232 - JP 2015513906-A/589: Stem Cell Microparticles.
HZ157498 - JP 2015130862-A/322: Micromirs.
HZ186364 - JP 2015146814-A/113: Oligonucleotides for modulating target RNA activity.
HZ406960 - JP 2015525081-A/25: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS.
HZ437013 - JP 2015529450-A/589: Stem Cell Microparticles.
HZ479847 - JP 2015535430-A/353: TERMINALLY MODIFIED RNA.
HZ789778 - JP 2016504050-A/1523: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287380 - Sequence 62 from Patent WO2011015720.
JA401430 - Sequence 677 from Patent WO2011080318.
JA402408 - Sequence 677 from Patent WO2011080315.
JA403415 - Sequence 677 from Patent WO2011080316.
JA406046 - Sequence 677 from Patent EP2336353.
JA429572 - Sequence 677 from Patent WO2011095623.
JB022702 - Sequence 544 from Patent WO2013026685.
JB620102 - Sequence 82 from Patent WO2013063544.
JB624211 - Sequence 31 from Patent EP2610342.
JB778678 - Sequence 57 from Patent WO2013078283.
JC172217 - Sequence 589 from Patent WO2013150303.
JC512510 - Sequence 2763 from Patent WO2014113089.
JC572016 - Sequence 30 from Patent EP2759595.
JC573028 - Sequence 589 from Patent WO2014125276.
JC582716 - Sequence 589 from Patent WO2014125277.
JE954412 - Sequence 589 from Patent WO2015052526.
JE956165 - Sequence 589 from Patent WO2015052527.
JE964807 - Sequence 25 from Patent EP2863956.
JE988628 - Sequence 3 from Patent WO2015121663.
LF132465 - JP 2016506923-A/30: Composition comprising an encapsulated antagomir.
LF137917 - JP 2016507550-A/589: Method of Producing Microparticles.
LF161049 - JP 2016513950-A/1115: Oligomers with improved off-target profile.
LF162882 - JP 2016513095-A/589: Stem Cell Microparticles and miRNA.
LF953634 - JP 2016534103-A/589: Stem Cell Microparticles and miRNA.
LG005979 - KR 1020150004822-A/589: STEM CELL MICROPARTICLES.
LG047729 - KR 1020150036140-A/25: Inhibitors of the MIR-15 Family of Micro-RNAs.
LG053675 - KR 1020150059168-A/589: STEM CELL MICROPARTICLES.
LG162329 - KR 1020160018451-A/30: Composition comprising an encapsulated antagomir.
LG240914 - KR 1020160035087-A/589: STEM CELL MICROPARTICLES AND MIRNA.
LP726492 - Sequence 186 from Patent EP2883966.
LP818762 - Sequence 186 from Patent EP3296406.
LP938704 - Sequence 186 from Patent EP3184651.
LQ070098 - Sequence 422 from Patent EP2964234.
LQ472195 - Sequence 41 from Patent WO2016115609.
LV470999 - JP 2016534036-A/589: Stem Cell Microparticles and miRNA.
LY405006 - KR 1020160117535-A/311: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233721 - JP 2017184756-A/113: Oligonucleotides for modulating target RNA activity.
MA260245 - JP 2017505623-A/311: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS833326 - Sequence 31 from Patent EP3112464.
MS834531 - Sequence 677 from Patent EP3112479.
MS902071 - Sequence 544 from Patent EP3156505.
LF935649 - JP 2016192918-A/1: A nucleic acid molecule for suppressing activity of pre-miRNA or shRNA.
DL491156 - Novel nucleic acids.
HZ459633 - WO 2015182781-A/336: Kit or device and method for detecting pancreatic cancer.
HZ460324 - WO 2015190542-A/330: Kit or device and method for detecting biliary tract cancer.
HZ461180 - WO 2015190584-A/677: Kit or device and method for detecting prostate cancer.
HZ462656 - WO 2015190591-A/811: Kit and method for detecting breast cancer.
HZ464826 - WO 2015194615-A/644: Kit or device and method for detecting hepatic cancer.
HZ465581 - WO 2015194627-A/634: Kit and method for detecting esophageal cancer.
LY481073 - KR 1020170010856-A/336: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495951 - KR 1020170015509-A/330: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496764 - KR 1020170018406-A/634: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498727 - KR 1020170018411-A/644: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499659 - KR 1020170018412-A/811: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY501053 - KR 1020170016490-A/677: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
MS869116 - Sequence 330 from Patent EP3156500.
MS869972 - Sequence 677 from Patent EP3156483.
MS880974 - Sequence 811 from Patent EP3156498.
MS994772 - Sequence 634 from Patent EP3159406.
AF480520 - Homo sapiens microRNA miR-16 gene, complete sequence.
AJ421734 - Homo sapiens microRNA miR-16.
AJ550396 - Homo sapiens microRNA mir-16-3.
CQ873605 - Sequence 24 from Patent WO2004076622.
CS166306 - Sequence 17 from Patent WO2005078096.
CS265274 - Sequence 16 from Patent EP1627925.
CS417787 - Sequence 15 from Patent WO2006048553.
CS444329 - Sequence 16 from Patent WO2006108473.
CS548301 - Sequence 1331 from Patent EP1777301.
DD328978 - Compositions and Methods for Cancer Diagnosis and Therapy.
DD413442 - Regulation of Mammalian Cells.
DI443393 - KR 1020140074997-A/14: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DI443394 - KR 1020140074997-A/15: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DJ087816 - Novel miRNA molecules isolated from human embryonic stem cell.
DJ442942 - METHOD FOR DETECTING ncRNA.
DL231846 - Method for the determination of cellular transcriptional regulation.
DL233836 - Identification of novel genes encoding for small temporal RNA.
DM119419 - Targeting Cells With Altered miRNA Expression.
DM119421 - Targeting Cells With Altered miRNA Expression.
DM168010 - COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND THERAPY OF BCL2-ASSOCIATED CANCERS.
DM174250 - COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE.
DM381420 - Novel Adenovirus vector comprising a structure of regulating transgene expression.
FU261358 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763860 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV523065 - Identification of novel genes encoding for small temporal RNA.
FV523918 - Diagnosis and therapeutic choice of head and neck tumor using micro RNA as biomarker.
FV524065 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker.
FV524261 - Nucleic acid controling mast cell degranulation.
FW312041 - DETECTING NUCLEIC ACIDS.
FW342844 - Diagnosis and therapeutic choice of head and neck tumor using micro RNA as biomarker.
FW345102 - Methods of suppressing the function of microRNAs.
FW360850 - MIR-15, MIR -26, MIR -31, MIR -145, MIR -147, MIR -188, MIR -215, MIR -216, MIR -331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION.
FW364050 - Oligonucleotides for modulating target RNA activity.
FW393854 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker.
FZ413530 - WO 2011001906-A/3: Method for evaluation of cultured cells.
FZ414178 - WO 2011007815-A/68: A method for screening a food which promotes production of milk having immunoregulating effect.
FZ414948 - WO 2011010737-A/31: Guide Nucleic Acid for Cleaving Micro RNA.
FZ415736 - JP 2010536372-A/16: METHODS OF USING MIRNA FOR DETECTION OF IN VIVO CELL DEATH.
HI416801 - Sequence 13 from Patent EP2136846.
HI560815 - Sequence 30 from Patent EP2190992.
HI560817 - Sequence 32 from Patent EP2190992.
HI571493 - Sequence 11 from Patent EP2219653.
HI965393 - Sequence 678 from Patent WO2010139812.
HI965769 - Sequence 89 from Patent WO2010139811.
HI966635 - Sequence 89 from Patent WO2010139810.
HI979170 - Sequence 97 from Patent EP2234483.
HV304759 - JP 2009531018-A/326: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305257 - JP 2009531019-A/326: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV321527 - JP 2011072229-A/34: Diagnosis and therapeutic choice of hypopharyngeal cancer using micro RNA as biomarker.
HV342552 - JP 2011510623-A/97: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV533150 - WO 2011105556-A/5: Marker for detection of dystrophy and detection method thereof.
HV540965 - WO 2011125469-A/9: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV541623 - WO 2011126089-A/5: Method for detecting of rhabdomyosarcoma using a sample from blood.
HV541624 - WO 2011126105-A/1: Examination method to determine contraction or activity of diseases related immune system or joint system.
HV544520 - JP 2011225570-A/4: Compositions and Methods for Cancer Diagnosis and Therapy.
HV593916 - JP 2010538653-A/30: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV593918 - JP 2010538653-A/32: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594940 - JP 2010539959-A/321: Micromirs.
HV821706 - JP 2011140513-A/68: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV943724 - JP 2012516688-A/200: METHODS OF DETECTING SEPSIS.
HV953914 - JP 2012518421-A/826: METHODS OF DETECTING LUNG CANCER.
HV956204 - JP 2012519484-A/1: LIVE ATTENUATED INFLUENZA VIRUS VACCINES COMPRISING MICRORNA RESPONSE ELEMENTS.
HW054994 - JP 2012526132-A/14: LIPOPHILIC POLYNUCLEOTIDE CONJUGATES.
HW060353 - JP 2012527478-A/17: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW061409 - JP 2012529295-A/14: Chemical Modification Motifs for miRNA Inhibitors and Mimetics.
HW101883 - JP 2013500034-A/10: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119466 - JP 2013046612-A/326: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW122380 - JP 2013504331-A/39: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
HW248804 - JP 2013514372-A/3: MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY.
HW289815 - JP 2013520158-A/58: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HW311971 - WO 2013125691-A/23: Method of Classification of Biological Fluid Test Sample.
HW340034 - JP 2013198483-A/23: Method of Classification of Biological Fluid Test Sample.
HW409068 - JP 2013226157-A/2: Novel Adenovirus vector comprising a structure of regulating transgene expression.
HW413583 - WO 2014003053-A/32: Method for screening pancreatic cancer and test kit therefor.
HW504666 - JP 2014503192-A/14: Base Modified Oligonucleotides.
HW504991 - JP 2014502491-A/14: Plasma Cell Disorders.
HW523241 - JP 2014507123-A/26: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW530021 - JP 2014094008-A/82: Identification of novel genes encoding for small temporal RNA.
HW576626 - JP 2014105183-A/1: Inhibitor of nucleic acid molecule for suppressing activity of RNAi molecule.
HW579309 - WO 2014084246-A/1: Inhibitor of nucleic acid molecule for suppressing activity of RNAi molecule.
HW589795 - JP 2013121348-A/326: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW596058 - JP 2013166766-A/4: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND THERAPY OF BCL2-ASSOCIATED CANCERS.
HW669779 - JP 2013537538-A/510: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW805173 - JP 2015007059-A/11: MICRO-RNAS OF THE MIR-15 FAMILY MODULATE CARDIOMYOCYTE SURVIVAL AND CARDIAC REPAIR.
HW807719 - JP 2014534810-A/14: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW807720 - JP 2014534810-A/15: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW823964 - JP 2015502176-A/25: Methods and Kits for Detecting Subjects at Risk of Having Cancer.
HW906810 - WO 2015037656-A/25: Autophagy-regulating microRNA.
HZ043115 - JP 2015510401-A/205: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043116 - JP 2015510401-A/206: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ073926 - JP 2013535982-A/17: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081741 - JP 2015514392-A/205: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ081742 - JP 2015514392-A/206: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082672 - JP 2015513906-A/29: Stem Cell Microparticles.
HZ157497 - JP 2015130862-A/321: Micromirs.
HZ186363 - JP 2015146814-A/112: Oligonucleotides for modulating target RNA activity.
HZ376445 - WO 2015133477-A/2: Method of aiding detection of pancreas cancer.
HZ392552 - JP 2015180203-A/58: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HZ406959 - JP 2015525081-A/24: INHIBITORS OF THE MIR-15 FAMILY OF MICRO-RNAS.
HZ413599 - JP 2014060993-A/326: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436453 - JP 2015529450-A/29: Stem Cell Microparticles.
HZ459413 - WO 2015182781-A/116: Kit or device and method for detecting pancreatic cancer.
HZ460029 - WO 2015190542-A/35: Kit or device and method for detecting biliary tract cancer.
HZ461110 - WO 2015190584-A/607: Kit or device and method for detecting prostate cancer.
HZ462085 - WO 2015190591-A/240: Kit and method for detecting breast cancer.
HZ464358 - WO 2015194615-A/176: Kit or device and method for detecting hepatic cancer.
HZ465136 - WO 2015194627-A/189: Kit and method for detecting esophageal cancer.
HZ474170 - WO 2016010047-A/1: Method for the detection of nucleic acid.
HZ479849 - JP 2015535430-A/355: TERMINALLY MODIFIED RNA.
HZ501810 - JP 2016025853-A/326: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789780 - JP 2016504050-A/1525: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287328 - Sequence 10 from Patent WO2011015720.
JA401431 - Sequence 678 from Patent WO2011080318.
JA402409 - Sequence 678 from Patent WO2011080315.
JA403416 - Sequence 678 from Patent WO2011080316.
JA406047 - Sequence 678 from Patent EP2336353.
JA427068 - Sequence 401 from Patent WO2011072177.
JA429573 - Sequence 678 from Patent WO2011095623.
JA462525 - Sequence 2 from Patent WO2011070297.
JA526176 - Sequence 326 from Patent EP2369011.
JA526683 - Sequence 326 from Patent EP2369012.
JA527190 - Sequence 326 from Patent EP2369013.
JA536119 - Sequence 326 from Patent EP2371971.
JA641962 - Sequence 82 from Patent EP2386637.
JA660732 - Sequence 186 from Patent WO2011131354.
JA663247 - Sequence 82 from Patent EP2385122.
JA663464 - Sequence 82 from Patent EP2385123.
JA667966 - Sequence 45 from Patent WO2011139911.
JA679057 - Sequence 200 from Patent EP2391738.
JA715044 - Sequence 826 from Patent EP2401406.
JA729542 - Sequence 1 from Patent EP2403527.
JA757871 - Sequence 4 from Patent WO2012010584.
JA781892 - Sequence 3 from Patent EP2513307.
JA788124 - Sequence 326 from Patent EP2479285.
JA788622 - Sequence 326 from Patent EP2479286.
JA810956 - Sequence 326 from Patent EP2468890.
JA811454 - Sequence 326 from Patent EP2468891.
JA811952 - Sequence 326 from Patent EP2468893.
JA812450 - Sequence 326 from Patent EP2468894.
JA812948 - Sequence 326 from Patent EP2468895.
JA813446 - Sequence 326 from Patent EP2468896.
JA813944 - Sequence 326 from Patent EP2468897.
JA814442 - Sequence 326 from Patent EP2468898.
JA814940 - Sequence 326 from Patent EP2468899.
JA817183 - Sequence 326 from Patent EP2468892.
JA825995 - Sequence 326 from Patent EP2471956.
JA826493 - Sequence 326 from Patent EP2471958.
JA829625 - Sequence 8 from Patent WO2013010906.
JA885396 - Sequence 26 from Patent WO2012083004.
JA885671 - Sequence 14 from Patent WO2012080721.
JB022659 - Sequence 501 from Patent WO2013026685.
JB023106 - Sequence 360 from Patent WO2013026684.
JB024780 - Sequence 326 from Patent EP2505668.
JB025278 - Sequence 326 from Patent EP2505669.
JB037893 - Sequence 9 from Patent WO2012107841.
JB073397 - Sequence 8 from Patent EP2546358.
JB073532 - Sequence 5 from Patent EP2546361.
JB075038 - Sequence 298 from Patent WO2012168448.
JB079665 - Sequence 326 from Patent EP2487252.
JB080163 - Sequence 326 from Patent EP2487253.
JB080661 - Sequence 326 from Patent EP2487254.
JB081159 - Sequence 326 from Patent EP2487255.
JB081657 - Sequence 326 from Patent EP2487256.
JB082155 - Sequence 326 from Patent EP2487257.
JB082653 - Sequence 326 from Patent EP2487258.
JB083151 - Sequence 326 from Patent EP2487259.
JB083649 - Sequence 326 from Patent EP2487260.
JB084147 - Sequence 326 from Patent EP2487261.
JB084645 - Sequence 326 from Patent EP2487262.
JB085143 - Sequence 326 from Patent EP2487263.
JB087821 - Sequence 326 from Patent EP2502630.
JB147335 - Sequence 3 from Patent EP2484779.
JB148025 - Sequence 326 from Patent EP2484782.
JB148523 - Sequence 326 from Patent EP2484783.
JB148993 - Sequence 68 from Patent EP2455486.
JB153248 - Sequence 326 from Patent EP2514433.
JB153746 - Sequence 326 from Patent EP2514434.
JB171294 - Sequence 5 from Patent EP2540829.
JB174999 - Sequence 31 from Patent WO2012101219.
JB224370 - Sequence 5 from Patent EP2557162.
JB233485 - Sequence 17 from Patent EP2437750.
JB235847 - Sequence 3 from Patent EP2450454.
JB249315 - Sequence 83 from Patent EP2478360.
JB292044 - Sequence 82 from Patent EP2428569.
JB302159 - Sequence 82 from Patent EP2428570.
JB320114 - Sequence 82 from Patent EP2428568.
JB336177 - Sequence 82 from Patent EP2428571.
JB361364 - Sequence 82 from Patent EP2428567.
JB616174 - Sequence 4 from Patent WO2013107459.
JB620101 - Sequence 81 from Patent WO2013063544.
JB622335 - Sequence 326 from Patent EP2586454.
JB622833 - Sequence 326 from Patent EP2586455.
JB624210 - Sequence 30 from Patent EP2610342.
JB624212 - Sequence 32 from Patent EP2610342.
JB748049 - Sequence 1 from Patent EP2557179.
JC001896 - Sequence 326 from Patent EP2591794.
JC019936 - Sequence 3 from Patent EP2644706.
JC032740 - Sequence 12 from Patent WO2013160474.
JC171657 - Sequence 29 from Patent WO2013150303.
JC244404 - Sequence 24 from Patent WO2012020308.
JC270119 - Sequence 510 from Patent WO2012020307.
JC334141 - Sequence 59 from Patent EP2487240.
JC512512 - Sequence 2765 from Patent WO2014113089.
JC572018 - Sequence 32 from Patent EP2759595.
JC572468 - Sequence 29 from Patent WO2014125276.
JC582156 - Sequence 29 from Patent WO2014125277.
JD587468 - Sequence 1 from Patent EP2825885.
JE829069 - Sequence 5 from Patent EP2829613.
JE844308 - Sequence 51 from Patent WO2015091897.
JE846306 - Sequence 8 from Patent WO2015095862.
JE953852 - Sequence 29 from Patent WO2015052526.
JE955605 - Sequence 29 from Patent WO2015052527.
JE964806 - Sequence 24 from Patent EP2863956.
JE978741 - Sequence 186 from Patent EP2865765.
JE988627 - Sequence 2 from Patent WO2015121663.
LF132467 - JP 2016506923-A/32: Composition comprising an encapsulated antagomir.
LF137357 - JP 2016507550-A/29: Method of Producing Microparticles.
LF139807 - JP 2016088896-A/4: Inhibitor of muscular cell damage.
LF161952 - JP 2016513950-A/2018: Oligomers with improved off-target profile.
LF162322 - JP 2016513095-A/29: Stem Cell Microparticles and miRNA.
LF404212 - JP 2015509366-A/205: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404213 - JP 2015509366-A/206: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF633366 - JP 2016515804-A/3: MICRORNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA.
LF636251 - JP 2016519076-A/25: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF642596 - JP 2016518826-A/14: BRIDGED BICYCLIC NUCLEOSIDES.
LF935657 - JP 2016192918-A/9: A nucleic acid molecule for suppressing activity of pre-miRNA or shRNA.
LF953074 - JP 2016534103-A/29: Stem Cell Microparticles and miRNA.
LG005419 - KR 1020150004822-A/29: STEM CELL MICROPARTICLES.
LG046473 - KR 1020150023687-A/18: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif.
LG047728 - KR 1020150036140-A/24: Inhibitors of the MIR-15 Family of Micro-RNAs.
LG053115 - KR 1020150059168-A/29: STEM CELL MICROPARTICLES.
LG110709 - KR 1020150130444-A/3: MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA.
LG134408 - KR 1020150131312-A/25: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG162331 - KR 1020160018451-A/32: Composition comprising an encapsulated antagomir.
LG240354 - KR 1020160035087-A/29: STEM CELL MICROPARTICLES AND MIRNA.
LP645545 - Sequence 14 from Patent WO2016022753.
LP726395 - Sequence 89 from Patent EP2883966.
LP754438 - Sequence 6 from Patent EP3280805.
LP769596 - Sequence 123 from Patent EP3294910.
LP803862 - Sequence 1 from Patent EP3266881.
LP818665 - Sequence 89 from Patent EP3296406.
LP871152 - Sequence 10 from Patent EP3254683.
LP901946 - Sequence 3 from Patent EP3180464.
LP917433 - Sequence 29 from Patent WO2017153710.
LP938607 - Sequence 89 from Patent EP3184651.
LP951496 - Sequence 2 from Patent WO2017157650.
LP958370 - Sequence 10 from Patent WO2017211617.
LQ068192 - Sequence 3 from Patent EP2968604.
LQ070100 - Sequence 424 from Patent EP2964234.
LQ101304 - Sequence 9 from Patent WO2015101653.
LQ276019 - Sequence 9 from Patent WO2016071729.
LQ278632 - Sequence 171 from Patent WO2016066288.
LQ405410 - Sequence 20 from Patent WO2016142688.
LQ420453 - Sequence 29 from Patent WO2016127998.
LQ441291 - Sequence 298 from Patent EP3029157.
LQ526010 - Sequence 7 from Patent WO2016139262.
LQ565003 - Sequence 28 from Patent WO2016139092.
LQ660989 - Sequence 10 from Patent EP3090058.
LQ664837 - Sequence 26 from Patent WO2016150475.
LQ724495 - Sequence 128 from Patent WO2018096084.
LQ840908 - Sequence 18 from Patent EP3354734.
LQ844109 - Sequence 29 from Patent WO2018138468.
LV470439 - JP 2016534036-A/29: Stem Cell Microparticles and miRNA.
LV539152 - JP 2016539127-A/153: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LV746093 - JP 2015521626-A/18: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
LX270576 - JP 2016056210-A/510: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LX280752 - JP 2016105097-A/39: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LY298554 - KR 1020160079824-A/153: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405005 - KR 1020160117535-A/310: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY480853 - KR 1020170010856-A/116: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495656 - KR 1020170015509-A/35: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496319 - KR 1020170018406-A/189: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498259 - KR 1020170018411-A/176: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499088 - KR 1020170018412-A/240: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500983 - KR 1020170016490-A/607: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY504685 - KR 1020170035932-A/74: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LY508003 - KR 1020170033439-A/14: TARGETING MICRORNAS FOR METABOLIC DISORDERS.
LZ215789 - JP 2017518753-A/140: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ233720 - JP 2017184756-A/112: Oligonucleotides for modulating target RNA activity.
LZ234370 - JP 2017181518-A/39: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LZ242966 - JP 2017525350-A/74: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA259112 - JP 2017502699-A/9: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA260244 - JP 2017505623-A/310: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA267563 - JP 2018061503-A/3: Method of detecting nucleic acids and kit therefor.
MA348830 - JP 2018506998-A/7: Simultaneous detection of oligonucleotides, a kit and a use related thereto.
MA353743 - JP 2018075017-A/205: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA353744 - JP 2018075017-A/206: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS637930 - Sequence 47 from Patent WO2017037190.
MS673557 - Sequence 360 from Patent EP3135774.
MS810722 - Sequence 8 from Patent EP3144395.
MS816871 - Sequence 220 from Patent WO2017085287.
MS833325 - Sequence 30 from Patent EP3112464.
MS833327 - Sequence 32 from Patent EP3112464.
MS834532 - Sequence 678 from Patent EP3112479.
MS868821 - Sequence 35 from Patent EP3156500.
MS869902 - Sequence 607 from Patent EP3156483.
MS880403 - Sequence 240 from Patent EP3156498.
MS902028 - Sequence 501 from Patent EP3156505.
MS944818 - Sequence 74 from Patent EP3177739.
MS994327 - Sequence 189 from Patent EP3159406.
MA643599 - JP 2017113010-A/1523: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731483 - JP 2017140048-A/353: TERMINALLY MODIFIED RNA.
MA643601 - JP 2017113010-A/1525: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730723 - JP 2017125065-A/510: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731485 - JP 2017140048-A/355: TERMINALLY MODIFIED RNA.
MA764910 - JP 2017523790-A/14: TARGETING MICRORNAS FOR METABOLIC DISORDERS.
MA765558 - JP 2017514519-A/124: Small ncRNAs as biomarkers.
MA388967 - JP 2018513685-A/6: Method for Blocking miRNA.
MA400936 - JP 2018515097-A/123: Method for Diagnosis and Prognosis of Chronic Heart Failure.
LQ970615 - Sequence 25 from Patent EP2800820.
MA420167 - JP 2018518169-A/218: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MP045492 - Sequence 314 from Patent EP3401394.
MP084162 - Sequence 314 from Patent EP3401393.
MP065905 - Sequence 19 from Patent WO2018228875.
MP075698 - Sequence 37 from Patent WO2019002265.
MP014840 - Sequence 43 from Patent WO2019016252.
MP045383 - Sequence 205 from Patent EP3401394.
MP045384 - Sequence 206 from Patent EP3401394.
MP070409 - Sequence 6 from Patent WO2018231851.
MP075697 - Sequence 36 from Patent WO2019002265.
MP084053 - Sequence 205 from Patent EP3401393.
MP084054 - Sequence 206 from Patent EP3401393.
MA800652 - JP 2018183181-A/1523: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800654 - JP 2018183181-A/1525: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129689 - Sequence 589 from Patent EP3470073.
MP162612 - Sequence 589 from Patent WO2019069093.
MP129129 - Sequence 29 from Patent EP3470073.
MP162052 - Sequence 29 from Patent WO2019069093.
MA896075 - JP 2017217007-A/18: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
MB017896 - JP 2018506997-A/28: SIGNATURE OF HEALTH.
MB018400 - JP 2018504915-A/29: A microRNA-based method for early detection of prostate cancer in urine samples.
MB021430 - JP 2019050772-A/1: A test method for predicting side reactions after vaccination.
MP202468 - Sequence 11 from Patent WO2019081607.
MP202782 - Sequence 11 from Patent WO2019081610.
MP264427 - Sequence 15 from Patent EP3502269.
MP280597 - Sequence 17 from Patent WO2019111197.
MP272059 - Sequence 7 from Patent WO2019157381.
MP283510 - Sequence 17 from Patent WO2019111198.
MB119567 - WO 2019117257-A/89: Method of aiding detection of breast cancer.
MB119750 - WO 2019117257-A/272: Method of aiding detection of breast cancer.
MB119569 - WO 2019117257-A/91: Method of aiding detection of breast cancer.
MB119568 - WO 2019117257-A/90: Method of aiding detection of breast cancer.
MB119941 - WO 2019117270-A/143: Method of aiding detection of head and neck cancer.
MB408328 - WO 2019163900-A/35: Method of analysis and diagnose using RNA modification.
MB408340 - WO 2019163900-A/47: Method of analysis and diagnose using RNA modification.
MB453625 - JP 2018509178-A/191: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.
MP495319 - Sequence 11 from Patent WO2020025710.
MP394921 - Sequence 19 from Patent EP3565903.
MP495318 - Sequence 10 from Patent WO2020025710.
MP549115 - Sequence 1 from Patent WO2020030750.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029486, uc318svs.1
UCSC ID: ENST00000385271.1
RefSeq Accession: NR_029486.1

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.